Registered Capital in China: How Much to Set & When to Pay (2026 Guide)

One of the most critical—and most misunderstood—parts of setting up a China company is registered capital. Under the revised China Company Law (effective July 1, 2024) and its stricter enforcement in 2026, the old “subscribe now, pay later forever” mindset is no longer safe.
You are now expected to set a reasonable number and follow a realistic injection schedule. Too high increases liability and tax/fees; too low can trigger bank onboarding issues and, in some cases, work visa planning constraints.
Need a practical capital plan for your city and industry? Talk to us
For related reading:
Pillar (full setup process)
Sibling (timeline & total setup cost)
TL;DR
The 5-year rule: For most companies, shareholders should plan to fully pay subscribed registered capital within 5 years of establishment. “Subscribed” does not mean “never paid.”
The “reasonable range” matters: Most industries have no statutory minimum, but banks and regulators care about credibility. Too high = unnecessary liability + more stamp duty; too low = banking friction.
Non-payment has consequences: Missing the schedule can lead to penalties, profit distribution restrictions, and accelerated liability risk (creditors may pursue unpaid capital).
Who this is for
Founders and SMEs planning startup budget and runway
CFOs and finance teams designing cross-border cash flow
Legal teams managing shareholder liability exposure
Investors evaluating compliance risk of an existing entity
HR teams forecasting foreign hiring and onboarding timelines
Key checklist
Before you finalize the Articles of Association (AoA), confirm these:
Industry benchmark in your city (e.g., services vs trading vs manufacturing)
Worst-case liability cap: do not set capital higher than you can support
Bank onboarding reality: some banks have practical “minimum expectations”
Hiring plan: align early staffing + office + tax needs with the injection schedule
Stamp duty awareness: 0.025% of paid-in amount when you inject
Injection schedule you can actually execute within 5 years
Step-by-step / How it works
Registered capital is a lifecycle item, not a one-time checkbox:
Decide amount + schedule at incorporation:You declare total capital and the injection plan in the AoA. This is a compliance commitment, not marketing copy.
Open the capital account (or bank structure designated for capital):Your bank will guide account type and documentation.
Transfer funds from overseas shareholders:Use the correct purpose/remark (commonly “Investment Capital” / “投资款”) so it’s treated as equity, not a loan.
(Optional) Capital verification / CPA report:Often not mandatory for standard industries, but banks/tax may still request supporting evidence.
Bookkeeping entry:Record as paid-in capital in accounting (e.g., 实收资本 / paid-in capital).
Pay capital stamp duty:File and pay 0.025% of the paid-in amount via the tax system within the applicable deadline.
Ongoing annual reporting:Update paid-in status in the annual corporate report (SAMR).
Documents / Inputs (if applicable)
Articles of Association (AoA): capital amount, currency, and schedule
Shareholder/board resolution approving injection
Bank remittance proof (with correct purpose/remark)
Capital verification report (if requested)
Tax filing records for stamp duty
Timeline & cost (typical)
Timeline
The decision is upfront; the injection can be staged.
Item | When | Notes |
|---|---|---|
Decide capital + schedule | Before incorporation | Drives AoA and bank expectations |
Injection window | Within 5 years | Usually in tranches (e.g., Year 1 + Year 2–5) |
Capital verification (if needed) | 3–5 working days after funds arrive | Depends on bank/tax requirements |
Cost drivers
Stamp duty: 0.025% of paid-in amount (e.g., $100k paid-in ≈ $25)
FX / conversion spread (USD/EUR → CNY)
Bank inbound remittance fees (often $20–$50 per transfer)
CPA report (if needed): often a few hundred USD depending on complexity
Opportunity cost: idle funds in a capital account typically earn minimal interest
Common mistakes (avoid these)
Setting an arbitrarily high number “for prestige”:Higher capital increases your liability ceiling and can increase tax/fee exposure.
Underestimating the 5-year compliance pressure:A schedule you can’t execute becomes a compliance and governance problem.
Using the wrong remittance purpose/remark:Funds may be treated as debt instead of equity, creating tax and reporting issues.
Ignoring bank expectations:“No statutory minimum” does not mean “any number is fine” for account opening.
Mismatched documents:AoA amount/schedule not matching bank records is a common cause of tax/audit friction.
Using third-party accounts for injection:Capital should come from the actual shareholder’s account to keep the audit trail clean.
FAQ
Q1 Do I have to pay registered capital immediately?
Usually not. Most companies inject capital in tranches. The key is having a credible schedule and executing it within the legal timeline.
Q2 Is there a minimum registered capital for a China WFOE?
For many general industries, there’s no statutory minimum. However, some regulated sectors still have minimums, and banks may apply practical thresholds.
Q3 Can I change registered capital later?
Often yes (via formal procedures and filings), but it’s not “free.” Plan your number and schedule carefully to avoid rework.
Q4 How is this different for WFOE vs JV vs Rep Office?
Rep Offices don’t have registered capital. WFOEs and JVs generally follow the same core registered capital rules, but JVs also need alignment with the JV contract and contribution ratios.
Q5 What happens if the company can’t pay debts before the 5 years ends?
A key risk is accelerated liability: creditors may pursue shareholders to pay unpaid subscribed capital earlier than planned.
If you want a defensible registered capital number and a compliant injection plan (AoA + banking + tax), we can help:Talk to us now to design your capital injection plan.
About the Author
Marcus
Marcus Yao is a Senior Managing Consultant with over 20 years of experience in finance and tax consulting. He focuses on company setup, compliance operations, and long-term advisory support for foreign-invested and cross-border businesses operating in China.